Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Hebert

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Tamoxifen in liver disease: potential exacerbation of hepatic dysfunctionL C Floren, M F Hebert, A P Venook, et al.
Transplantation|March 30, 1999
Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipientsM F Hebert, N L Ascher, J R Lake, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporineC Y Wu, L Z Benet, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|July 1, 1997
Tacrolimus oral bioavailability doubles with coadministration of ketoconazoleL C Floren, I Bekersky, L Z Benet, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine PharmacokineticsS K Quinney, A N Mohamed, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategiesM A Andrew, T R Easterling, D B Carr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2009
Clonidine pharmacokinetics in pregnancyM L Buchanan, T R Easterling, D B Carr, et al.
Clinical Pharmacology and Therapeutics|October 18, 2012
Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus dispositionS Zheng, Y Tasnif, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research studyM F Hebert, T R Easterling, B Kirby, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Pharmacokinetics of tacrolimus in liver transplant patientsW J Jusko, W Piekoszewski, G B Klintmalm, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
Tamoxifen in liver disease: potential exacerbation of hepatic dysfunctionL C Floren, M F Hebert, A P Venook, et al.
Transplantation|March 30, 1999
Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipientsM F Hebert, N L Ascher, J R Lake, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporineC Y Wu, L Z Benet, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|July 1, 1997
Tacrolimus oral bioavailability doubles with coadministration of ketoconazoleL C Floren, I Bekersky, L Z Benet, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine PharmacokineticsS K Quinney, A N Mohamed, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategiesM A Andrew, T R Easterling, D B Carr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2009
Clonidine pharmacokinetics in pregnancyM L Buchanan, T R Easterling, D B Carr, et al.
Clinical Pharmacology and Therapeutics|October 18, 2012
Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus dispositionS Zheng, Y Tasnif, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research studyM F Hebert, T R Easterling, B Kirby, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Pharmacokinetics of tacrolimus in liver transplant patientsW J Jusko, W Piekoszewski, G B Klintmalm, et al.
Pageof 3